A blog of no uncertain musings. What goes on in my mind is often a source of wonder to me. |
June is over, a month never to be repeated. And we're now on the downward slide to the end of 2025. I wish to thank StephBee and Ẃeβ࿚Ẃỉtcĥ for sponsoring a Blogging contest in June as part of "The Bard's Hall Contest" ![]() And a huge THANKS to all the members, friends and family who have frequented my blog, sending your encouragement. I hadn't been a regular blogger before. I have to say, it's growing on me. Plus, these entries are something I can leave for my kids--who knows, they may even like reading them. On to my news of the day. I met yesterday with an Oncologist with the University of Kansas Cancer Center to determine further treatment plans for me. I arrived thinking the consultation was to see if I qualified for any on-going immunotherapy clinical trials for my specific strain of kidney cancer. It turns out I'm part of a very small group of only 15% of folks with my strain of kidney cancer. My doctor strongly advised me not to pursue the rather new trials for that 15% group. Her reasoning made absolute sense. Those trials are designed for persons who have Stage 4 kidney cancer, which has metastasized (or spread) to other areas of the body, especially lymph nodes, lungs, bones, etc. I'm at Stage 3 as determined by the successful surgery to remove a lone, though large tumor and the right kidney to which it was attached. My cancer has not metastasized. She explained the history of the more than 20 years of trials for the 85% group. Big Pharma is loath to put large sums of money into testing and developing drugs for such small groups. That's why all the testing has been done for the tens of thousands of patients (85%) over those 20-plus years, thereby making big bucks for the pharmaceutical companies. (This is me paraphrasing; my doctor was much more diplomatic with her explanation.) She concluded by saying the breakthrough for treatment of that 85% has only come in the past two years. Side effects, some extremely severe, plagued those trials for many years. She believed any benefits I might receive from the newer trials for my strain would be far overshadowed by potentially severe side effects. My best course of action would be to implement a series of CT scans every three months for the first couple years, moving to twice a year for a couple years, and then, if scans were still warranted, annually. My situation would be reevaluated after each scan. It's not that "do nothing" option; but it allows me to continue living without ill side effects, while checking me out periodically. I've not been pronounced cured, but I am more hopeful for the future. |